Beta Bionics, Inc. Common Stock BBNX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$66.44M+9.2% | -$73.2M+6.0% | -$77.84M-6.1% | -$73.37M-3.4% | -$70.96M-29.6% | ||
| $1.86M+17.9% | $1.57M+24.2% | $1.27M+4.3% | $1.22M+4.1% | $1.17M+1.4% | ||
| $18.99M+15.9% | $16.38M+20.2% | $13.63M+22.5% | $11.13M+42.1% | $7.83M+22.7% | ||
| -$54.78M-7.6% | -$50.93M+10.0% | -$56.58M+1.5% | -$57.46M-2.4% | -$56.1M-16.2% | ||
| $6.34M+19.7% | $5.3M+33.9% | $3.96M-13.9% | $4.59M+38.3% | $3.32M-2.2% | ||
| —— | —— | —— | —— | -$190.24M-5,373% | ||
| $4.38M-98.0% | $214.87M-20.6% | $270.71M+1.4% | $266.88M+0.1% | $266.73M+380% | ||
| —— | —— | —— | —— | $20.38M+427% | ||
| -$61.12M-8.7% | -$56.22M+7.1% | -$60.53M+2.5% | -$62.06M-4.4% | -$59.43M-15.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beta Bionics, Inc. Common Stock generate?
- Beta Bionics, Inc. Common Stock (BBNX) generated -$54.8M in operating cash flow over the trailing twelve months.
- What is Beta Bionics, Inc. Common Stock's free cash flow?
- After $6.3M of capital expenditures, Beta Bionics, Inc. Common Stock's free cash flow was -$61.1M over the trailing twelve months, down 2.9% year over year.
- Where does Beta Bionics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
